A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

PHASE2CompletedINTERVENTIONAL
Enrollment

693

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

LCQ908A

DRUG

LCQ908A

DRUG

LCQ908A

DRUG

LCQ908A

DRUG

LCQ908A

DRUG

Placebo

DRUG

Sitagliptin

DRUG

metformin

Trial Locations (67)

Unknown

Clinical Research Advantage, Mesa

Mesa Family Medical Center/Clinical Research Advantage, Mesa

Woodland International Reserach Group, LLC, Little Rock

Associated Pharmaceutical Research, Buena Park

John Muir Clinical Research, Concord

*Private Practice*, Pasadena

Apex Research of Riverside, Riverside

California Research Foundation, San Diego

CNRI-San Diego, LLC, San Diego

Orange County Research Center, Tustin

Diablo Clinical, Walnut Creek

Denver VA Medical Center, Denver

Complete Family Care, Northglenn

Research Center Phase I-IV of Florida, Corp., Miami

Metabolic Research Institute, Inc., West Palm Beach

Perimeter North Medical Research, Roswell

MacNeal Center for Clinical Research, Berwyn

Venture Resource Group, Overland Park

Cotton-O'Neil Clinical Research Center Topeka KS United States, Topeka

Graves Gilbert Clinic Bowling Green KY United States, Bowling Green

Commonwealth Biomedical Research, LLC, Madisonville

Centennial Medical Group, Elkridge

International Research Center Towson MD United States, Towson

Fallon Clinic Worcester MA United States, Worcester

Southwestern Medical Clinic, Bridgman

Clarkston Medical Group, Clarkston

Michigan State University - Kalamazoo Ctr for Med Studies, Kalamazoo

Mississippi Medical Research, LLC, Picayune

ClinVest Research, Springfield

St. John's Clinic - Medical Research, Springfield

Montana Medical Research, Missoula

Meera Dewan, P.C., Omaha

Libra Clinical Research Associates, Brick

Physicians Research Center, Toms River

Endwell Family Physician, Endwell

*Private Practice* Staten Island, Staten Island

Medical Frontiers LLC, Carlisle

Radiant Research, Greer

Southwind Medical Specialists Memphis TN United States, Memphis

Dallas Diabetic and Endocrinology Research Center, Dallas

Radiant Research - North Dallas, Dallas

Accurate Clinical Research, Houston

Blalock Clinical Research, Houston

Texas Center for Drug Development, P.A., Houston

Ettrick Health Center, Ettrick

McGuire Veterans Medical Center, Richmond

Northwest Clinical Research, Bellevue

Providence Physicians Group, Monroe

Health Sciences Centre - Diabetes Research Group, Winnipeg

Rivergrove Medical Clinic, Winnipeg

Credit Valley Prof Bldg, Mississauga

Hamilton Medical Research Group, Sherbrooke

Hopital Maisonneuve-Rosemont, Montreal

Institut de Recherches Cliniques, Montreal

Clinique Médicale Millénia Santé, Québec

CHUS - Hopital Fleurimont, Sherbrooke

Azienda Ospedaliera-Ospedali Riuniti di Bergamo, Bergamo

Centro Studi sull'Invecchiamento CeSI-Univers.G.D'Annunzio, Chieti

A.O.Polo Universitario Luigi Sacco, Milan

Istituto Scientifico San Raffaele - IRCCS, Milan

Ospedale S.Giovanni di Dio, Olbia

Presidio Ospedaliero di Cisanello Università degli Studi, Pisa

Univ.Tor Vergata - AUSL ROMA B - Sede Territoriale, Roma

Samodzielny Publiczny Zaklad Opieki Zdrowotnej, Oława

Policlinica Dr. Luis Rodriguez Carrasquillo, Carolina

Endocrine Lipid Diabetes Research Institute Ponce PR United States, Ponce

Miguel Sosa-Padilla, M.D., San Juan

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY